Join Dementia Research latest newsView all news →
FEATURED ARTICLE
31 October 2024
Donanemab – an update
Last week it was announced that the dementia drug, donanemab, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). This means it will be available under private...